Clinical Trials List
2020-12-01 - 2025-12-31
Phase IV
Recruiting3
Terminated3
ICD-10E10.21
Type 1 diabetes mellitus with diabetic nephropathy
ICD-10E11.21
Type 2 diabetes mellitus with diabetic nephropathy
ICD-10N16
Renal tubulo-interstitial disorders in diseases classified elsewhere
ICD-9583.81
Nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 郭佑民 Division of Rheumatology
- 呂政勳 Division of Rheumatology
- PING-NING HSU Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Han Tsai Division of Rheumatology
- Yun Ju Huang Division of Rheumatology
- 張哲慈 Division of Rheumatology
- 謝孟儒 Division of Rheumatology
- Yao-Fan Fang Division of Rheumatology
- Yun Chen Tsai Division of Rheumatology
- 尤瀚華 Division of Rheumatology
- Chen-I Hsieh Division of Rheumatology
- 蕭朝陽 Division of Rheumatology
- TianMing Zhan Division of Rheumatology
- 黃思偉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳沂達 Division of Rheumatology
- HSIN-HUA CHEN Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- 陳怡行 Division of Rheumatology
- 曾智偉 Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- 陳韻文 Division of Rheumatology
- 賴國隆 Division of Rheumatology
- 譚國棟 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 廖育婉 Division of Rheumatology
- 顏在弘 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 曾文逸 Division of Rheumatology
- Yun Chen Tsai Division of Rheumatology
- 吳詹永嬌 Division of Rheumatology
- TianMing Zhan Division of Rheumatology
- 張哲慈 Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
- 蕭朝陽 Division of Rheumatology
- 黃思偉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
64 participants
-
Global
NA participants